| 000 | 01843 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516215517.0 | ||
| 264 | 0 | _c20140930 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1091-6490 | ||
| 024 | 7 |
_a10.1073/pnas.1319810111 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMottolese, Raphaelle | |
| 245 | 0 | 0 |
_aSwitching brain serotonin with oxytocin. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cJun 2014 |
||
| 300 |
_a8637-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmygdala _xmetabolism |
| 650 | 0 | 4 |
_aBinding, Competitive _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aFrontal Lobe _xmetabolism |
| 650 | 0 | 4 |
_aGyrus Cinguli _xmetabolism |
| 650 | 0 | 4 |
_aHippocampus _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOxytocin _xadministration & dosage |
| 650 | 0 | 4 |
_aPiperazines _xmetabolism |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 |
_aPyridines _xmetabolism |
| 650 | 0 | 4 |
_aRaphe Nuclei _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, Serotonin, 5-HT1A _xmetabolism |
| 650 | 0 | 4 |
_aSerotonin _xmetabolism |
| 650 | 0 | 4 |
_aSerotonin 5-HT1 Receptor Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aRedouté, Jérôme | |
| 700 | 1 | _aCostes, Nicolas | |
| 700 | 1 | _aLe Bars, Didier | |
| 700 | 1 | _aSirigu, Angela | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 111 _gno. 23 _gp. 8637-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.1319810111 _zAvailable from publisher's website |
| 999 |
_c23902536 _d23902536 |
||